Recognizing the importance of a continued commitment to ending pediatric HIV/AIDS worldwide.

Legislation Details

Recognizes the significance of a sustained commitment to ending pediatric HIV/AIDS globally.
Highlights that approximately 1.4 million children are living with HIV as of 2023.
Notes that HIV is a leading cause of death among women of childbearing age and adolescent girls.
Emphasizes the importance of pre- and post-natal care for screening and health management.
States that antiretroviral drugs can reduce mother-to-child transmission of HIV to less than 5%.
Reports an increase in treatment for pregnant and breastfeeding women living with HIV from 17% in 2005 to 84% in 2023.
Indicates that 44% of new HIV infections globally are among women and girls.
Mentions that 67% of infants born to HIV-positive mothers receive a virologic test within the first two months.
Warns that without treatment, half of all children with HIV will die by their second birthday.
Points out that 86% of children living with HIV are in sub-Saharan Africa.
Notes that over 110,000 children in sub-Saharan Africa became infected with HIV in 2022.
Highlights slower progress in meeting global treatment targets for children compared to adults.
Reports that 57% of children living with HIV were on antiretroviral therapy in 2023.
States that 76,000 children died from AIDS-related causes in 2023.
Indicates that approximately 4,000 adolescent girls and young women become infected with HIV weekly.
Acknowledges research breakthroughs for children at risk of HIV.
Celebrates the 21st anniversary of the U.S. International Mother and Child HIV Prevention Initiative and PEPFAR.
Notes that PEPFAR has supported HIV testing for over 71 million people and helped nearly 5.5 million babies be born HIV-free.
Supports initiatives aimed at reducing new HIV infections among adolescent girls and young women.
Calls for continued U.S. leadership in the global fight against pediatric HIV.
Advocates for increased access to counseling, testing, and treatment services for women and children.
Encourages the development of a standalone pediatric HIV strategy aligned with global priorities.
Reaffirms the U.S. commitment to eliminate new pediatric HIV infections and support affected families.

Recognizing the importance of a continued commitment to ending pediatric HIV/AIDS worldwide.

Cosponsors